<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="unravel. This demands a wide index of suspicion for prompt" exact="diagnosis" post="of SARS-CoV-2 to prevent further complications and mortality. RÃ‰SUMÃ‰"/>
 <result pre="and mortality. RÃ‰SUMÃ‰ : Les impacts neurologiques et neuropsychiatriques dâ€™une" exact="infection" post="Ã la COVID-19. Contexte : Bien quâ€™il sâ€™agisse principalement"/>
 <result pre="possesses an acetyl-esterase function, which may be important during early" exact="infection" post="or during the release of viral particles from the"/>
 <result pre="aminopeptidase-N.35 Similar findings have also been demonstrated by SARS-CoV.34,36,37 Following" exact="infection" post="of these cell lines, monocytes get activated, differentiate into"/>
 <result pre="other tissues, including the nervous system.27,32,33,36 On the other hand," exact="infection" post="of dendritic cells results in wavering of innate immunity,"/>
 <result pre="subsequently result in hypoxic brain injuries.39 Inflammation-Related Neurovirulence The viral" exact="infection" post="is also known to propagate via a cytokine storm"/>
 <result pre="have shown neurologic involvement as the presenting feature of SARS-CoV-2" exact="infection" post="or have reported post-infectious neurologic complications.3,42,56â€&quot;58 Broadly speaking, these"/>
 <result pre="mechanisms of viral entry into the olfactory epithelium. Firstly, local" exact="infection" post="of the vascular and sustentacular cells in the nasal"/>
 <result pre="&amp;lt;50 years, sometimes occurring earlier in the course of viral" exact="infection" post="as compared to an average duration of 10â€&quot;12 d61,84"/>
 <result pre="has proved, time and again, that recent viral or bacterial" exact="infection" post="is quite a plausible cause of cerebrovascular ischemia,84 and"/>
 <result pre="the given circumstances that we consider the linkage of COVID-19" exact="infection" post="with the occurrence of coagulopathy and increased risk of"/>
 <result pre="study by Helms etÂ al.87 also had 87.7% of patients" exact="testing" post="positive for lupus anticoagulant (LA), which is an anti-phospholipid"/>
 <result pre="in dilute Russell Viper venom reagents. Cellular damage due to" exact="infection" post="possibly causes plasma membrane remodelling and exposure of otherwise"/>
 <result pre="she failed to show any response to the usually followed" exact="treatment" post="protocols for viral meningoencephalitis that COVID-19 testing was ordered.96"/>
 <result pre="the usually followed treatment protocols for viral meningoencephalitis that COVID-19" exact="testing" post="was ordered.96 She was started on hydroxychloroquine, showing improvement"/>
 <result pre="changes.91 Encephalopathy in patients with COVID-19 does not involve a" exact="diagnosis" post="of viral encephalitis. Other causes behind an encephalopathy-like clinical"/>
 <result pre="neurological ailments have been seen to suffer from more severe" exact="infection" post="and are at a greater risk of encephalopathy at"/>
 <result pre="mind SARS-CoV-2 infections while dealing with such cases as expeditious" exact="isolation" post="of positive cases is deemed indispensable to stall further"/>
 <result pre="with epilepsy and whether it increases the risk of contracting" exact="infection" post="remain unclear as of now. No definite association between"/>
 <result pre="rationale is that a mounting systemic response to the viral" exact="infection" post="triggered this status.102 Non-compliance to medication could be a"/>
 <result pre="encephalopathy. Neurological manifestation in this case was antecedent to a" exact="diagnosis" post="of SARS-CoV-2 infection.105 Post-viral acute cerebellar ataxia is quite"/>
 <result pre="cause, Mycoplasma pneumoniae being the most common.109 Myelitis following an" exact="infection" post="with Epstein-Barr virus, cytomegalovirus, measles virus or rhinovirus is"/>
 <result pre="cord involvement. Only one case of acute myelitis following COVID-19" exact="infection" post="has been described from Wuhan hitherto.110 It is only"/>
 <result pre="and SARS-CoV-2 Skeletal muscle damage (myopathy) in association with SARS-CoV-2" exact="infection" post="has been observed to range from asymptomatic rises in"/>
 <result pre="neuropathy and critical illness myopathy in patients with severe SARS-CoV-2" exact="infection" post="requiring mechanical ventilation. The use of non-depolarising neuromuscular blocking"/>
 <result pre="al.58 from Wuhan, several cases of GBS related to SARS-CoV-2" exact="infection" post="have been reported so far.57,58,115â€&quot;120 Toscano etÂ al.115 described"/>
 <result pre="is too early to conclude any definite association between SARS-CoV-2" exact="infection" post="and this milder variety of MFS.121 RT-PCR tests done"/>
 <result pre="higher in those taking fingolimod, natalizumab or rituximab.127 Consequently, COVID-19" exact="infection" post="was diagnosed in an MS patient under treatment with"/>
 <result pre="Consequently, COVID-19 infection was diagnosed in an MS patient under" exact="treatment" post="with fingolimod in May 2020 from Iran.128 Severity of"/>
 <result pre="against SARS-CoV-2 have been developed. It is unavoidable that a" exact="diagnosis" post="of new neurological disorders will be delayed due to"/>
 <result pre="directed at this, healthcare being targeted largely at the prevention," exact="diagnosis" post="and management of COVID-19. There was a definite fall"/>
 <result pre="increasing demand and strain on the healthcare system regarding the" exact="diagnosis" post="and treatment of all the non-emergent conditions, which were"/>
 <result pre="and strain on the healthcare system regarding the diagnosis and" exact="treatment" post="of all the non-emergent conditions, which were put away"/>
 <result pre="especially crucial in patients of acute stroke, given that specific" exact="treatment" post="therapies within specified time windows (thrombolysis/thrombectomy/medical therapy) are known"/>
 <result pre="Stroke patients may have symptomatic as well as asymptomatic COVID-19" exact="infection" post="or may develop fever during an hospital stay due"/>
 <result pre="develop fever during an hospital stay due to urinary tract" exact="infection" post="or aspiration pneumonia as a complication of stroke, thus"/>
 <result pre="in providing care to patients of acute stroke with COVID-19" exact="infection" post="do have a risk of contracting the infection from"/>
 <result pre="with COVID-19 infection do have a risk of contracting the" exact="infection" post="from them, although the exact risk is yet to"/>
 <result pre="for Managing Stroke During Covid-19131â€&quot;140 First, apart from the regular" exact="screening" post="methods used by paramedics before transferring the patient to"/>
 <result pre="to appropriate centres, COVID-19 pandemic mandates the use of additional" exact="screening" post="protocol, including that of an infection control screen and"/>
 <result pre="the use of additional screening protocol, including that of an" exact="infection" post="control screen and a travel history screen for all"/>
 <result pre="on the recommendations of WHO or CDC.1,141,142 They must complete" exact="screening" post="the patient for infection, assessing for features such as"/>
 <result pre="stroke patients may also be in the prodromal phase of" exact="infection" post="or being asymptomatic carriers. The paramedics should be instructed"/>
 <result pre="for such patients also and continue with such protocols until" exact="screening" post="can be reliably completed or COVID-19 ruled out with"/>
 <result pre="testing. Efficient communication across transfer sites and adherence to local" exact="screening" post="procedures needs to be highlighted at this point. Second,"/>
 <result pre="filtering face-piece respirator may be reconsidered based on availability, regional" exact="prevalence" post="of SARS-CoV-2 infection and institutional practices. As a routine,"/>
 <result pre="may be reconsidered based on availability, regional prevalence of SARS-CoV-2" exact="infection" post="and institutional practices. As a routine, full-sleeved gown, extended"/>
 <result pre="possible, keeping in mind that those at risk of contracting" exact="infection" post="are best kept back. The fruitful use of tele-stroke"/>
 <result pre="A suspect or confirmed case must be admitted in an" exact="isolation" post="ward afterwards, keeping suspects apart from confirmed cases. Fifth,"/>
 <result pre="these times. A tracheobronchial aspirate may be sent for SARS-CoV-2" exact="detection" post="at the same time. Given that several steps in"/>
 <result pre="epilepsies, for instance, which make the person more susceptible to" exact="infection" post="both due to the disease process itself and as"/>
 <result pre="as part of therapy, and it is irrefutable that severe" exact="infection" post="is often associated with underlying cardiovascular comorbidities. Certain combinations"/>
 <result pre="everolimus to prevent viral infections.147,148 A major drawback in the" exact="treatment" post="of epilepsies and seizures is the limited use of"/>
 <result pre="procedures. Moreover, neurologists may consider postponement of any changes in" exact="treatment" post="(such as weaning off or change in therapies, elective"/>
 <result pre="often seen to not understand the measures of hygiene and" exact="social distancing" post="laid down by the authorities. Sometimes, even if they"/>
 <result pre="Alzheimerâ€™s or Parkinsonâ€™s disease even in the setting of COVID-19" exact="infection" post="to prevent further complications of the underlying illness. The"/>
 <result pre="it may be reasonable to continue treatment. Considerations for stopping" exact="treatment" post="may be undertaken in those taking drugs with greater"/>
 <result pre="Fourth, a higher threshold should be assumed before offering corticosteroid" exact="treatment" post="to MS patients during COVID-19 pandemic, and it is"/>
 <result pre="immunosuppression (dimethyl fumarate, teriflunomide) can be safe to start, but" exact="treatment" post="continuation requires regular monitoring of leukocyte count, which may"/>
 <result pre="degree of immunosuppression (cladribine, alemtuzumab) mandate delaying further courses of" exact="treatment" post="based on disease status, patient factors as well as"/>
 <result pre="present. Eighth, patients of neuromyelitis optical spectrum disorders should continue" exact="treatment" post="to prevent relapses, including corticosteroids, azathioprine, mycophenolate mofetil, tocilizumab,"/>
 <result pre="this pandemic. Lastly, it is always advised to provide individualized" exact="treatment" post="based on patient factors, disease status and drug effects."/>
 <result pre="and economic strata of the society. There is an increasing" exact="prevalence" post="of depression, anxiety, sleep and stress disorders among medical"/>
 <result pre="A study from Ethiopia showed a threefold increase in the" exact="prevalence" post="of depression in April 2020.141 Surveys across China have"/>
 <result pre="excessive workload, uncertainties of prognoses, shortages of resources for testing," exact="treatment" post="and personal protection, feelings of quandary, dilemmas about the"/>
 <result pre="the population. In addition to the growing concerns regarding SARS-CoV-2" exact="infection" post="and its precariousness faced by the general population, older"/>
 <result pre="the age group of 15â€&quot;49 years.141 On the other hand," exact="social distancing," post="limited celebrations and unavailability of addictive substance can lead"/>
 <result pre="schizophrenia later in life.162,163 Severance etÂ al.164 established an increased" exact="prevalence" post="of antibodies against four HCoV strains in patients with"/>
 <result pre="completely shut oneâ€™s eyes to these conceivable problems of SARS-CoV-2" exact="infection" post="in the long run. So how do we terminate"/>
 <result pre="in quandary as to how to provide mental healthcare in" exact="isolation" post="units and hospitals. The integration of mental health crisis"/>
 <result pre="crisis interventions with the general disposition of disease prevention and" exact="treatment" post="is of indispensable value. Multidisciplinary mental health teams, both"/>
 <result pre="to allay their fears and anxiety to some extent. Regular" exact="screening" post="of suspected patients, confirmed cases and health workers for"/>
 <result pre="It is critical that people continue to have access to" exact="treatment" post="and be provided with the correct information to reduce"/>
 <result pre="generation. Apart from SARS-CoV-2-related neurological manifestations, other neurological disorders requiring" exact="treatment" post="with IST/IMT must be dealt with great caution. The"/>
 <result pre="and burn-out during this pandemic would further complicate diagnostic and" exact="treatment" post="perspectives. Funding This research was supported by FEDER funds."/>
 <result pre="Infect Dis2008;6(3):114â€&quot;24.18486065 16.EscaffreO, BorisevichV, RockxB.Pathogenesis of Hendra and Nipah virus" exact="infection" post="in humans. J Infect Dev Countr2013;7(04):308â€&quot;11. 17.DrexlerJ, Gloza-RauschF, GlendeJ,"/>
 <result pre="J Virol2000;74(19):8913â€&quot;21.10982334 28.ArbourN, CÃ´tÃ©G, LachanceC, TardieuM, CashmanN, TalbotP.Acute and persistent" exact="infection" post="of human neural cell lines by human coronavirus OC43."/>
 <result pre="J Virol1999;73(4):3338â€&quot;50.10074188 29.ArbourN, EkandÃ©S, CÃ´tÃ©G, LachanceC, ChagnonF, M t. persistent" exact="infection" post="of human oligodendrocytic and neuroglial cell lines by human"/>
 <result pre="OC43. J Virol1997;71(1):800â€&quot;6.8985420 31.XuJ, ZhongS, LiuJ, LiL, LiY, X w." exact="detection" post="of severe acute respiratory syndrome coronavirus in the brain:"/>
 <result pre="pathogenesis. Clin Infect Dis.2005;41(8):1089â€&quot;96.16163626 32.GuJ, GongE, ZhangB, et al.Multiple organ" exact="infection" post="and the pathogenesis of SARS. J Exp Med.2005;202(3):415â€&quot;24.16043521 33.DesforgesM,"/>
 <result pre="Exp Med.2005;202(3):415â€&quot;24.16043521 33.DesforgesM, MilettiT, GagnonM, TalbotP.Activation of human monocytes after" exact="infection" post="by human coronavirus 229e. virus research. Virus Res.2007;130(1â€&quot;2):228â€&quot;40.17669539 34.CollinsA.In"/>
 <result pre="by human coronavirus 229e. virus research. Virus Res.2007;130(1â€&quot;2):228â€&quot;40.17669539 34.CollinsA.In vitro" exact="detection" post="of apoptosis in monocytes/macrophages infected with human coronavirus. Clin"/>
 <result pre="Chem Neurosci2020;11(7):995â€&quot;8.32167747 42.WuY, XuX, ChenZ, et al.Nervous system involvement after" exact="infection" post="with COVID-19 and other coronaviruses. Brain Behav Immun.2020;87:18â€&quot;22.32240762 43.VerdecchiaP,"/>
 <result pre="Eur J Intern Med.2020;76:14â€&quot;20.32336612 44.VargaZ, FlammerAJ, SteigerP, et al.Endothelial cell" exact="infection" post="and endotheliitis in COVID-19. Lancet.2020;395(10234):1417â€&quot;8.32325026 45.TsaiLK, HsiehST, ChangYC.Neurological manifestations"/>
 <result pre="113(1):e73â€&quot;6.14702500 51.LauKK, YuWC, ChuCM, LauST, ShengB, YuenKY.Possible central nervous system" exact="infection" post="by SARS coronavirus. Emerg Infect Dis.2004;10(2):342â€&quot;4.15030709 52.KimJE, HeoJH, KimHO,"/>
 <result pre="Emerg Infect Dis.2004;10(2):342â€&quot;4.15030709 52.KimJE, HeoJH, KimHO, et al.Neurological complications during" exact="treatment" post="of Middle East respiratory syndrome. J Clin Neurol2017;13(3):227â€&quot;33.28748673 53.SaadM,"/>
 <result pre="as stroke. Brain Behav Immun2020;87:115â€&quot;9.32360439 84.GrauAJ, BuggleF, HeindlS, et al.Recent" exact="infection" post="as a risk factor for cerebrovascular ischemia. Stroke1995;26(3):373â€&quot;9.7886709 85.BenussiA,"/>
 <result pre="Behav Immun.2020;87:149.32387508 95.McAbeeGN, BrosgolY, PavlakisS, AghaR, GaffoorM.Encephalitis associated with COVID-19" exact="infection" post="in an 11 year-old child. Pediatr Neurol.2020;S0887â€&quot;8994(20)30143â€&quot;0. 96.DuongL, XuP,"/>
 <result pre="without respiratory failure in a young female patient with COVID-19" exact="infection" post="in downtown Los Angeles, early April 2020. Brain Behav"/>
 <result pre="2019: retrospective study. BMJ. 2020;368:m1091.32217556 126.HermanC, MayerK, SarwalA.Scoping review of" exact="prevalence" post="of neurologic comorbidities in patients hospitalized for COVID-19. Neurology.2020;95(2):77â€&quot;84.32345728"/>
 <result pre="study. Mult Scler Relat Disord.2020;41:101982.32070858 128.BarzegarM, MirmosayyebO, NehzatN, et al.COVID-19" exact="infection" post="in a patient with multiple sclerosis treated with fingolimod."/>
 <result pre="al.Pattern of informed consent acquisition in patients undergoing emergent endovascular" exact="treatment" post="for acute ischemic stroke. J Vasc Interv Neurol.2014;7(2):21â€&quot;5. 137.KimDH,"/>
 <result pre="StrbianD, et al.Helsinki Stroke Thrombolysis Registry Group. Body temperature, blood" exact="infection" post="parameters, and outcome of thrombolysis-treated ischemic stroke patients. Int"/>
 <result pre="146.collab: CDC COVID-19 Response Team, et al.Preliminary estimates of the" exact="prevalence" post="of selected underlying health conditions among patients with coronavirus"/>
 <result pre="Rep.2020;69(13):382â€&quot;6.32240123 147.HillJA, HummelM, StarlingRC, et al.A lower incidence of cytomegalovirus" exact="infection" post="in deÂ novo heart transplant recipients randomized to everolimus."/>
 <result pre="systematic review and meta-analysis. BMJ.2015;350:h2538.26041151 162.KhandakerGM, ZimbronJ, DalmanC, LewisG, JonesPB.Childhood" exact="infection" post="and adult schizophrenia: a meta-analysis of population-based studies. Schizophr"/>
 <result pre="of population-based studies. Schizophr Res.2012;139(1â€&quot;3):161â€&quot;8.22704639 163.SteinbergD, HirschSR, MarstonSD, ReynoldsK, SuttonRN.Influenza" exact="infection" post="causing manic psychosis. Br J Psychiatry1972;120(558):531â€&quot;5.5041533 164.SeveranceEG, DickersonFB, ViscidiRP,"/>
</results>
